Manchester Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Hold |
9,850
| – | – | 0.02% | 428 |
|
|
2025
Q1 | $73.2K | Hold |
9,850
| – | – | 0.01% | 480 |
|
|
2024
Q4 | $59.1K | Hold |
9,850
| – | – | 0.01% | 516 |
|
|
2024
Q3 | $50.4K | Hold |
9,850
| – | – | 0.01% | 538 |
|
|
2024
Q2 | $35.7K | Hold |
9,850
| – | – | ﹤0.01% | 560 |
|
|
2024
Q1 | $31.6K | Buy |
+9,850
| New | +$31.6K | ﹤0.01% | 512 |
|
|
2023
Q4 | – | Sell |
-9,850
| Closed | -$53.7K | – | 1002 |
|
|
2023
Q3 | $53.7K | Hold |
9,850
| – | – | 0.01% | 404 |
|
|
2023
Q2 | $66.1K | Hold |
9,850
| – | – | 0.01% | 386 |
|
|
2023
Q1 | $87K | Buy |
+9,850
| New | +$87K | 0.01% | 373 |
|
|
2022
Q4 | – | Sell |
-7,795
| Closed | -$56K | – | 993 |
|
|
2022
Q3 | $56K | Buy |
7,795
+4,695
| +151% | +$33.7K | 0.01% | 350 |
|
|
2022
Q2 | $25K | Hold |
3,100
| – | – | ﹤0.01% | 394 |
|
|
2022
Q1 | $43K | Buy |
+3,100
| New | +$43K | 0.01% | 407 |
|
|
2021
Q4 | – | Sell |
-2,820
| Closed | -$96K | – | 999 |
|
|
2021
Q3 | $96K | Buy |
2,820
+2,620
| +1,310% | +$89.2K | 0.01% | 366 |
|
|
2021
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 510 |
|
|
2021
Q1 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 491 |
|